Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 775 of 984 entries
View as:

First-in-Human Study of TAK-280 in Participants With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05220098 Org: User:
Start: 04/22/22 End: 06/30/25 Due: 06/30/26

Efficacy and Safety of Dexlansoprazole MR Compared to Placebo on Maintaining Healing in Subjects With Healed Erosive Esophagitis

Phase: N/A Priority: Normal
NCT ID: NCT00321737 Org: User:
Start: 05/31/06 End: 05/31/07 Due: 05/31/08

A Survey on NINLARO Risk Management Plan (RMP) Material Utilization Among Pharmacists in Japan

Phase: N/A Priority: Normal
NCT ID: NCT05882279 Org: User:
Start: 06/01/23 End: 06/09/23 Due: 06/09/24

Expanded Access Program of TAK-755 for Congenital Thrombotic Thrombocytopenic Purpura (cTTP)

Phase: N/A Priority: Normal
NCT ID: NCT05770219 Org: User:
Start: - End: - Due: -

An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT02497469 Org: User:
Start: 06/29/15 End: 01/18/19 Due: 01/18/20

A Study of Soticlestat in Adults and Children With Rare Epilepsies

Phase: N/A Priority: Normal
NCT ID: NCT03635073 Org: User:
Start: 07/19/18 End: 05/22/26 Due: 05/22/27

Ixazomib Rollover Study

Phase: N/A Priority: Normal
NCT ID: NCT02924272 Org: User:
Start: 12/16/16 End: 07/03/24 Due: 07/03/25

A Clinical Trial With Intranasal Fentanyl in Cancer Patients With Breakthrough Pain

Phase: N/A Priority: Normal
NCT ID: NCT01429051 Org: User:
Start: 08/31/11 End: 01/31/13 Due: 01/31/14

A Study of the Burden of Illness and Treatment Patterns in Teenagers and Adults With Hereditary Angioedema

Phase: N/A Priority: Normal
NCT ID: NCT04957641 Org: User:
Start: 04/21/22 End: 01/13/23 Due: 01/13/24

Efficacy of Candesartan on Symptomatic Heart Failure in Treating Diabetic and Hypertensive Patients.

Phase: N/A Priority: Normal
NCT ID: NCT00775840 Org: User:
Start: 01/31/08 End: 12/31/08 Due: 12/31/09

A Single- and Multiple-Dose Study of the Pharmacokinetics of TAK-491 in Healthy Chinese Participants

Phase: N/A Priority: Normal
NCT ID: NCT02541669 Org: User:
Start: 11/20/15 End: 03/17/17 Due: 03/17/18

A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 52 Weeks of Treatment

Phase: N/A Priority: Normal
NCT ID: NCT06088043 Org: User:
Start: 11/06/23 End: 04/15/26 Due: 04/15/27

A Study of Maribavir in Japanese People With Cytomegalovirus (CMV) Infection

Phase: N/A Priority: Normal
NCT ID: NCT05137717 Org: User:
Start: 01/18/22 End: 06/27/23 Due: 06/27/24

Leuprorelin Acetate SR 11.25 mg for Injection Specified Drug-use Survey "Long-term Use Survey on Premenopausal Breast Cancer Patients (96 Weeks)"

Phase: N/A Priority: Normal
NCT ID: NCT02154139 Org: User:
Start: 12/31/05 End: 03/31/10 Due: 03/31/11

Norovirus Bivalent-Vaccine Efficacy Study

Phase: N/A Priority: Normal
NCT ID: NCT01609257 Org: User:
Start: 07/16/12 End: 03/18/14 Due: 03/18/15

Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) at the End of Shelf Life in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT03771963 Org: User:
Start: 03/28/19 End: 03/13/20 Due: 03/13/21

Bioequivalence Study of Dexlansoprazole Capsules From Two Manufacturing Plants

Phase: N/A Priority: Normal
NCT ID: NCT03131895 Org: User:
Start: 04/25/17 End: 07/31/17 Due: 07/31/18

A Study of Pevonedistat Combined With Decitabine and Cedazuridine in Adults With Higher-risk Myelodysplastic Syndromes

Phase: N/A Priority: Normal
NCT ID: NCT04985656 Org: User:
Start: 10/01/21 End: 11/08/24 Due: 11/08/25

Safety Study of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00762112 Org: User:
Start: 11/30/03 End: 12/31/04 Due: 12/31/05

Phase 1, TAK-915-1001, Single-Rising Dose, Multiple-Rising Dose, Drug-Drug Interaction, Relative Bioavailability, Food Effect, and Effect on Elderly Participants Study

Phase: N/A Priority: Normal
NCT ID: NCT02461160 Org: User:
Start: 05/12/15 End: 08/01/16 Due: 08/01/17

A Study of Danavorexton in Anesthetized Adults

Phase: N/A Priority: Normal
NCT ID: NCT05025397 Org: User:
Start: 09/28/21 End: 03/08/22 Due: 03/08/23

Safety and Tolerability of Multiple Doses of ITI-214 in Healthy Adults and in Adults With Stable Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT01900522 Org: User:
Start: 07/31/13 End: 12/31/14 Due: 12/31/15

This is a Multicenter, Prospective and Retrospective and Descriptive Epidemiology Study in Patients With Chronic Obstructive Pulmonary Disease (COPD) in Korea

Phase: N/A Priority: Normal
NCT ID: NCT01419379 Org: User:
Start: 07/31/11 End: 01/31/13 Due: 01/31/14

Post Trial Access Program of TAK-577 for Von Willebrand Disease (VWD)

Phase: N/A Priority: Normal
NCT ID: NCT06173024 Org: User:
Start: - End: - Due: -

A Study of Vedolizumab in Children and Teenagers with Moderate to Severe Ulcerative Colitis (UC)

Phase: N/A Priority: Normal
NCT ID: NCT04779307 Org: User:
Start: 04/18/22 End: 08/30/25 Due: 08/30/26